In August 2001, the extremely popular cholesterol lowering drug Baycol (generic: cerivastatin) was removed from the U.S. market due to its being linked to over 100 deaths. Specifically, Baycol was linked to “Rhabdomyolysis”, which is a condition that can lead to kidney failure and death.
Do I Have a Baycol Rhabdomyolysis Lawsuit? If you or a loved one have taken Baycol or Cerivastatin and suffered from any side effects including Rhabdomyolysis, kidney failure, renal failure or death, you should contact us immediately. You may be entitled to compensation and we can help.
According to the U.S. Food & Drug Administration (FDA) at the time of withdrawal, it had received 31 reports of deaths. The FDA cited that U.S. Baycol induced deaths were caused by Rhabdomyolysis associated with Baycol use.
In December 2004, the Journal of the American Medical Association published a study showing that the risk of developing Rhabdomyolysis from the use of Baycol combined with gemfibrozil was 10 times higher than for other statins. The study also showed that approximately 1 in 10 patients would develop rhabdomyolysis.
Since the time of the original market withdrawal, Baycol has been linked to over 100 deaths due to Rhabdomyolysis, kidney failure, renal failure and/or liver toxicity. Another 385 nonfatal cases of rhabdomyolysis have been reported. This put the risk of this (rare) complication at 5-10 times that of the other cholesterol lowering drugs.
Baycol is a synthetic member of the class of statins, used to lower “bad cholesterol” (LDL) and prevent cardiovascular disease. Baycol works by promoting the production of “good cholesterol” high-density lipoproteins (HDL) that lowers the artery-clogging risk of high levels of LDL.
Baycol was marketed by pharmaceutical giant, Bayer A.G.
Rhabdomyolysis (pronounced: “rab-do my OHL-uh-sis") is an extremely rare condition wherein skeletal muscle is damaged causing a release of toxins into the bloodstream.
In other words, Rhabdomyolysis causes the rapid breakdown of skeletal muscle tissue. The muscle damage or destruction of muscle associated with Rhabdomyolysis leads to the release of “damaged muscle cells” into the bloodstream, which then leads to the risk of acute renal failure.
The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Baycol lawsuits. We are handling individual litigation nationwide and currently accepting new Rhabdomyolysis cases in all 50 states.
Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.
Free Confidential Case Evaluation
Toll Free 24 hrs/day (866) 588-0600
Secure 128-bit SSL Encrypted Email Communication - Click Here.
Secure 1024-bit SSL Encrypted Live Chat Communication - Click Here.
= Required Field